News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PAREXEL International (PRXL) Cuts Clinical Trial Start-Up Time For Sponsors By Weeks With New Version Of Industry-Leading ClinPhone® RTSM Services



6/16/2014 11:11:51 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Latest RTSM technology features standardized study components for faster implementation and greater design flexibility

London, 16 June, 2014 – PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organisation, today announced the launch of a new version of its industry standard ClinPhone® RTSM services designed to help clients start clinical trials more quickly. The leading edge randomisation and trial supply management (RTSM) solution has been used in more than 3,000 studies involving over 400,000 sites and two million patients since 1993. Developed by PAREXEL Informatics, it is a key component of the Perceptive MyTrials® platform, an integrated suite of applications for managing clinical trials.

Biopharmaceutical companies are increasingly seeking to make drug development more efficient without compromising patient safety or data quality. Efficiency is particularly critical at the start of clinical trials, when clients must simultaneously initiate a broad range of important activities such as patient screening, enrollment and randomisation, as well as drug dispensation and supply distribution.

Addressing these issues, ClinPhone® RTSM can be more rapidly implemented using pre-built, interactive web modules for patient, supply and site activities common to every study. PAREXEL Informatics can also streamline system review and approval for clients via an efficient visual design approach.

“Based upon our experience across thousands of studies, we have identified ways to standardise common functionality for patient screening, medication re-supply and other fundamental study activities,” said Xavier Flinois, President of PAREXEL Informatics. “Our customers can simplify trial management activities, and ultimately start their trials more quickly, using our powerful and flexible RTSM technology.”

“There is a growing need for faster, more efficient clinical trials, yet conducting them has become increasingly complex,” said Mark A. Goldberg, M.D., President and Chief Operating Officer, PAREXEL. “Trial success often hinges on start-up speed and effectiveness. At PAREXEL, we view drug development as a journey, and have made considerable investments in developing cutting-edge technology to help simplify it from beginning to end.”

ClinPhone® RTSM is available through the Perceptive MyTrials® platform and as a standalone solution. ClinPhone® RTSM and the Perceptive MyTrials® platform are also available through the Perceptive® Partner Program.

# # #

About PAREXEL International

PAREXEL International Corporation is a leading global biopharmaceutical services organisation, providing a broad range of knowledge-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. PAREXEL Informatics provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 75 locations in 50 countries around the world, and has approximately 15,335 employees. For more information about PAREXEL International visit www.PAREXEL.com.

PAREXEL, Perceptive, Perceptive MyTrials, ClinPhone, and “Your Journey. Our Mission.” are trademarks or registered trademarks of PAREXEL International Corporation or its affiliates.

Press contacts:
onechocolate communications
Sue Grant and Charlotte Ward
Tel. +44 (0)20 7437 0227
Parexel@onechocolatecomms.co.uk

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES